Literature DB >> 5310275

Von Willebrand factor and platelet adhesiveness.

D Meyer, M J Larrieu.   

Abstract

A modification of Salzman's method has been used in an attempt to provide an assay in vitro for the von Willebrand factor. Platelet adhesiveness was increased in von Willebrand's disease by previously coating the beads with normal or haemophilic plasma or cryoprecipitate, whereas von Willebrand plasma had no corrective effect. Antihaemophilic factor (AHF) concentrates were studied in the same way and results compared with experiments in vivo.

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5310275      PMCID： PMC474529          DOI： 10.1136/jcp.23.3.228

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  13 in total

1.  In vitro abnormality of the blood in von Willebrand's disease correctable by normal plasma.

Authors:  M B ZUCKER
Journal:  Nature       Date:  1963-02-09       Impact factor: 49.962

2.  Von Willebrand's disease and its correction with human plasma fraction 1-0.

Authors:  I M NILSSON; M BLOMBACK; E JORPES; B BLOMBACK; S A JOHANSSON
Journal:  Acta Med Scand       Date:  1957-11-29

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  The effect of plasma proteins on the interaction of platelets with glass surfaces.

Authors:  M A Packham; G Evans; M F Glynn; J F Mustard
Journal:  J Lab Clin Med       Date:  1969-04

5.  [Analysis of platelet functions: measurement of the adhesiveness of platelets to glass on whole blood (Salzman method)].

Authors:  D Meyer; M J Larrieu
Journal:  Rev Fr Etud Clin Biol       Date:  1967 Aug-Sep

6.  The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial.

Authors:  E J Hershgold; J G Pool; A R Pappenhagen
Journal:  J Lab Clin Med       Date:  1966-01

7.  Purification of antihemophilic factor (AHF) for clinical and experimental use.

Authors:  A J Johnson; J Newman; M B Howell; S Puszkin
Journal:  Thromb Diath Haemorrh Suppl       Date:  1967

8.  Some interactions between human platelets and glass: von Willebrand's disease compared with normal.

Authors:  J R O'Brien; J B Heywood
Journal:  J Clin Pathol       Date:  1967-01       Impact factor: 3.411

9.  Biological findings in Von Willebrand's pedigrees: implications for inheritance.

Authors:  D Meyer; M J Larrieu; P Maroteaux; J P Caen
Journal:  J Clin Pathol       Date:  1967-03       Impact factor: 3.411

10.  Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease (report of thirty-seven patients).

Authors:  M J Larrieu; J P Caen; D O Meyer; H Vainer; Y Sultan; J Bernard
Journal:  Am J Med       Date:  1968-09       Impact factor: 4.965
View more
  3 in total

1.  von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.

Authors:  R R Montgomery; T S Zimmerman
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

2.  Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.

Authors:  H J Weiss; J Rogers; H Brand
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

Review 3.  The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.

Authors:  Felice Gragnano; Simona Sperlongano; Enrica Golia; Francesco Natale; Renatomaria Bianchi; Mario Crisci; Fabio Fimiani; Ivana Pariggiano; Vincenzo Diana; Andreina Carbone; Arturo Cesaro; Claudia Concilio; Giuseppe Limongelli; Mariagiovanna Russo; Paolo Calabrò
Journal:  Mediators Inflamm       Date:  2017-05-28       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.